POST SUMMARY: Online communities can be a valuable patient resource, but safeguards have to be in place. Using patient data for retargeting or other monetary reasons is going to turn patients off.
Category Archive: Bad practices
POST SUMMARY: Not only do patients have to worry about which drug company paid their physician, they need to determine if their generic drug is the same as the branded equivalent and if their insurance company will allow their doctor to write for a specific medication. What is pharma doing to help patients navigate the complex world of empowered patient choices?
POST SUMMARY: Physicians do not prescribe an Rx because they are getting paid by drug companies. Actually, they are more likely to prescribe a certain product because of insurance companies and managed care incentives.
POST SUMMARY: Eight out of 10 prescriptions written in the United States are filled with the no-brand name, generic version of the drug prescribed by a doctor. The FDA mandates that generic forms of prescription medication contain the same active ingredient as the brand name, but the agency allows the generic version to use different inactive ingredients, including binders to hold the pill together and time release agents to disperse it.
POST SUMMARY: Low levels of adherence are extremely expensive. The main take home point of a CVS Health study is that we need to look more closely at drug adherence in the community setting, not just for disease management, but for cost containment as well.
POST SUMMARY: A strategy to force switch patients into more expensive medication as a branded medication comes off patent is among the dumbest ideas any CEO could put forward.